Alison D. Findlay

The Au(I)-Catalyzed Intramolecular Hydroarylation of Terminal Alkynes Under Mild Conditions: Application to the Synthesis of 2<i>H</i>-Chromenes, Coumarins, Benzofurans, and Dihydroquinolines

Rajeev S. Menon, Alison D. Findlay, Alex C. Bissember et al. · The Journal of Organic Chemistry · 2009 · 176 citations

Terminal Alkynes, Cross-coupling Reaction, Engineering +13

A first-in-class pan-lysyl oxidase inhibitor impairs stromal remodeling and enhances gemcitabine response and survival in pancreatic cancer

Jessica L. Chitty, Michelle Yam, Lara Perryman et al. · Nature Cancer · 2023 · 109 citations · Full text

The lysyl oxidase like 2/3 enzymatic inhibitor, PXS‐5153A, reduces crosslinks and ameliorates fibrosis

Heidi Schilter, Alison D. Findlay, Lara Perryman et al. · Journal of Cellular and Molecular Medicine · 2018 · 107 citations · Full text

Pre-clinical evaluation of small molecule LOXL2 inhibitors in breast cancer

Joan Chang, Morghan C. Lucas, Lidia E. Leonte et al. · Oncotarget · 2017 · 106 citations · Full text

Breast Oncology, Biochemistry, Loxl2 Activity +12

Identification and Optimization of Mechanism-Based Fluoroallylamine Inhibitors of Lysyl Oxidase-like 2/3

Alison D. Findlay, Jonathan S. Foot, Alberto Buson et al. · Journal of Medicinal Chemistry · 2019 · 54 citations · Full text